Atea Pharmaceuticals, Inc.

Nasdaq:AVIR

Pharmaceutical Preparations·BOSTON, MA

Atea is a deity in several Polynesian cultures, including the Marquesas and Tuamotu Islands, and New Zealand.

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	3/5/26	→
10-Q	Q3 2025	9/30/25	11/12/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/12/25	→
10-K	FY 2024	12/31/24	3/6/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→
↓

Earnings Releases (8-K)

23 shown

Filed	Period
3/5/26	Q1 FY2026	→
1/8/26	Q4 FY2026	→
11/12/25	Q4 FY2025	→
8/7/25	Q3 FY2025	→
5/12/25	Q2 FY2025	→
4/17/25	Q1 FY2025	→
↓

News (8-K)

15 shown

Filed	Type	Description
6/20/25	Vote	Submission of Matters to a Vote of Security Holders	→
4/1/25	Other	Other Events	→
3/24/25	Other	Other Events	→
2/24/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
6/21/24	Vote	Submission of Matters to a Vote of Security Holders	→
6/21/23	Vote	Amendments to Articles of Incorporation or Bylaws	→
↓

Prospectuses & Registrations

11 shown

Filed	Form	Description
8/7/25	S-8	S-8	→
11/7/24	S-3	S-3	→
4/28/23	ARS	ARS	→
2/28/22	POSASR	POSASR	→
11/24/21	S-3ASR	S-3ASR	→
10/30/20	S-8	S-8	→
↓

Filing History(292 filings)

TypeDateAccessionPeriodSize

10-K

Mar 5, 2026

0001193125-26-09415910-K

Dec 31, 2025

15.9 MB

8-K

Mar 5, 2026

0001193125-26-0939618-K

Mar 5, 2026

219.4 KB

SCHEDULE 13G

Feb 9, 2026

0001373604-26-000010

—

7.8 KB

Feb 3, 2026

0001193125-26-0362814

Jan 31, 2026

12.4 KB

Feb 3, 2026

0001193125-26-0362724

Jan 31, 2026

13.1 KB

Feb 3, 2026

0001193125-26-0362704

Jan 31, 2026

12.6 KB

Feb 3, 2026

0001193125-26-0362694

Jan 31, 2026

12.6 KB

Feb 3, 2026

0001193125-26-0362684

Jan 31, 2026

14.5 KB

Feb 3, 2026

0001193125-26-0362614

Jan 31, 2026

12.4 KB

8-K

Jan 8, 2026

0001193125-26-0070818-K

Jan 8, 2026

179.1 KB

SCHEDULE 13G/A

Dec 5, 2025

0000315066-25-002957

—

11.3 KB

10-Q

Nov 12, 2025

0001193125-25-27781510-Q

Sep 30, 2025

9.0 MB

8-K

Nov 12, 2025

0001193125-25-2776278-K

Nov 12, 2025

219.9 KB

S-8

Aug 7, 2025

0001193125-25-175553S-8

—

190.5 KB

10-Q

Aug 7, 2025

0000950170-25-10512310-Q

Jun 30, 2025

8.7 MB

8-K

Aug 7, 2025

0001193125-25-1754338-K

Aug 7, 2025

209.4 KB

SCHEDULE 13G/A

Aug 6, 2025

0000315066-25-001974

—

10.8 KB

Jun 24, 2025

0000950170-25-0896074

Jun 20, 2025

11.1 KB

Jun 24, 2025

0000950170-25-0896094

Jun 20, 2025

11.1 KB

Jun 24, 2025

0000950170-25-0896064

Jun 20, 2025

11.1 KB

Jun 24, 2025

0000950170-25-0896054

Jun 20, 2025

11.1 KB

Jun 24, 2025

0000950170-25-0896084

Jun 20, 2025

11.1 KB

Jun 24, 2025

0000950170-25-0896044

Jun 20, 2025

11.1 KB

Jun 24, 2025

0000950170-25-0896034

Jun 20, 2025

5.1 KB

Jun 24, 2025

0000950170-25-0895963

Jun 20, 2025

17.6 KB

25 filings shown

Filed	Form	Description
4/29/25	DEF 14A	DEF 14A	→
4/3/25	DEFA14A	DEFA14A	→
4/1/25	DEFA14A	DEFA14A	→
3/26/25	DEFA14A	DEFA14A	→
3/24/25	DEFA14A	DEFA14A	→
6/4/24	DEFA14A	DEFA14A	→
↓

Atea Pharmaceuticals, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(292 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/3/26	4	4	→
2/3/26	4	4	→
2/3/26	4	4	→
2/3/26	4	4	→
2/3/26	4	4	→
2/3/26	4	4	→
↓

Filed	Form	Description
2/9/26	SCHEDULE 13G	SCHEDULE 13G	→
12/5/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
8/6/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
5/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
4/23/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
4/17/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
↓